enGene Therapeutics Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4enGene Therapeutics Inc.ENGNWSep 24

   William Grossman, insider filing for ENGNW

   William Grossman, reporting

2. NOTABLE10-QenGene Therapeutics Inc.ENGNWSep 8

   Quarterly report

3. ROUTINE8-KenGene Therapeutics Inc.ENGNWSep 8

   Current report

4. ROUTINESCHEDULE 13G/AenGene Therapeutics Inc.ENGNWAug 14

   2 13G filings

   Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

   Show all 2

   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14
   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14

   PERCEPTIVE ADVISORS LLC, filed by

5. ROUTINESCHEDULE 13G/AenGene Therapeutics Inc.ENGNWAug 14

   Ownership stake disclosure by Deep Track Capital, LP (amended)

   Deep Track Capital, LP, filed by

6. ROUTINESCHEDULE 13G/AenGene Therapeutics Inc.ENGNWAug 13

   Ownership stake disclosure by Invus Global Management, LLC (amended)

   Invus Global Management, LLC, filed by

7. ROUTINESCHEDULE 13G/AenGene Therapeutics Inc.ENGNWAug 12

   Ownership stake disclosure by Blue Owl Capital Holdings LP (amended)

   Blue Owl Capital Holdings LP, filed by

8. ROUTINE8-KenGene Therapeutics Inc.ENGNWAug 11

   Current report

9. ROUTINE3enGene Therapeutics Inc.ENGNWJul 22

   2 insider filings

   Kathleen P. Richton, new insider at ENGNW

   Show all 2

   • 3New insider at ENGNWJul 22
   • 3New insider at ENGNWJul 22

   Kathleen P. Richton, reporting

10. ROUTINESCHEDULE 13GenGene Therapeutics Inc.ENGNWJul 22

    Ownership stake disclosure by ACORN BIOVENTURES, L.P.

    ACORN BIOVENTURES, L.P., filed by

11. ROUTINE8-KenGene Therapeutics Inc.ENGNWJul 17

    Current report

12. ROUTINE8-KenGene Therapeutics Inc.ENGNWJul 16

    Current report

13. ROUTINE8-K/AenGene Therapeutics Inc.ENGNWJun 18

    Current report (amended)

14. ROUTINE4enGene Therapeutics Inc.ENGNWJun 17

    8 insider filings

    Philip Astley-Sparke, insider filing for ENGNW

    Show all 8

    • 4Insider filing for ENGNWJun 17
    • 4Insider filing for ENGNWJun 17
    • 4Insider filing for ENGNWJun 17
    • 4Insider filing for ENGNWJun 17
    • 4Insider filing for ENGNWJun 17
    • 4Insider filing for ENGNWJun 17
    • 4Insider filing for ENGNWJun 17
    • 4Insider filing for ENGNWJun 17

    Philip Astley-Sparke, reporting

15. NOTABLE10-QenGene Therapeutics Inc.ENGNWJun 15

    Quarterly report

16. ROUTINE8-KenGene Therapeutics Inc.ENGNWJun 15

    Current report

17. ROUTINE8-KenGene Therapeutics Inc.ENGNWJun 10

    Current report

18. ROUTINESCHEDULE 13G/AenGene Therapeutics Inc.ENGNWMay 15

    Ownership stake disclosure by Cormorant Asset Management, LP (amended)

    Cormorant Asset Management, LP, filed by

19. ROUTINESCHEDULE 13G/AenGene Therapeutics Inc.ENGNWMay 14

    Ownership stake disclosure by BML Investment Partners, L.P. (amended)

    BML Investment Partners, L.P., filed by

20. ROUTINESCHEDULE 13GenGene Therapeutics Inc.ENGNWMay 13

    Ownership stake disclosure by BML Investment Partners, L.P.

    BML Investment Partners, L.P., filed by

21. ROUTINEARSenGene Therapeutics Inc.ENGNWMay 8

    Annual report to shareholders

22. ROUTINEDEF 14AenGene Therapeutics Inc.ENGNWMay 8

    Proxy statement

23. ROUTINE8-KenGene Therapeutics Inc.ENGNWMay 7

    Current report

24. ROUTINESCHEDULE 13G/AenGene Therapeutics Inc.ENGNWMay 5

    Ownership stake disclosure by Invus Global Management, LLC (amended)

    Invus Global Management, LLC, filed by

25. ROUTINE8-KenGene Therapeutics Inc.ENGNWApr 9

    Current report

26. ROUTINES-8enGene Holdings Inc.ENGNWMar 9

    Employee stock plan registration

27. ROUTINE424B5enGene Holdings Inc.ENGNWMar 9

    Securities offering

28. ROUTINE8-KenGene Holdings Inc.ENGNWMar 9

    Current report

29. NOTABLE10-QenGene Holdings Inc.ENGNWMar 9

    Quarterly report

30. ROUTINE8-KenGene Holdings Inc.ENGNWMar 9

    Current report

31. ROUTINEEFFECTenGene Holdings Inc.ENGNWMar 3

    Registration declared effective

32. ROUTINES-3enGene Holdings Inc.ENGNWFeb 19

    Securities offering

33. ROUTINE10-K/AenGene Holdings Inc.ENGNWFeb 19

    Annual report (amended)

34. ROUTINESCHEDULE 13G/AenGene Holdings Inc.ENGNWFeb 17

    Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P. (amended)

    Venrock Healthcare Capital Partners III, L.P., filed by

35. ROUTINESCHEDULE 13GenGene Holdings Inc.ENGNWFeb 17

    Ownership stake disclosure by Cormorant Asset Management, LP

    Cormorant Asset Management, LP, filed by

36. ROUTINESCHEDULE 13G/AenGene Holdings Inc.ENGNWFeb 17

    Ownership stake disclosure by Kynam Capital Management, LP (amended)

    Kynam Capital Management, LP, filed by

37. ROUTINE4enGene Holdings Inc.ENGNWFeb 3

    5 insider filings

    Anthony Tzeyew Cheung, insider filing for ENGNW

    Show all 5

    • 4Insider filing for ENGNWFeb 3
    • 4Insider filing for ENGNWFeb 3
    • 4Insider filing for ENGNWFeb 3
    • 4Insider filing for ENGNWFeb 3
    • 4Insider filing for ENGNWFeb 3

    Anthony Tzeyew Cheung, reporting

Older filings on EDGAR